Hemagen Diagnostics (Hemagen Diagnostics) COGS-to-Revenue : 0.54 (As of Sep. 2012)

View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics COGS-to-Revenue?

Hemagen Diagnostics's Cost of Goods Sold for the three months ended in Sep. 2012 was $0.47 Mil. Its Revenue for the three months ended in Sep. 2012 was $0.88 Mil.

Hemagen Diagnostics's COGS to Revenue for the three months ended in Sep. 2012 was 0.54.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Hemagen Diagnostics's Gross Margin % for the three months ended in Sep. 2012 was 45.89%.

Hemagen Diagnostics COGS-to-Revenue Historical Data

The historical data trend for Hemagen Diagnostics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics COGS-to-Revenue Chart

Hemagen Diagnostics Annual Data

Trend

Sep03

Sep04

Sep05

Sep06

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

COGS-to-Revenue

Get a 7-Day Free Trial

0.57

0.62

0.55

0.62

0.60

Hemagen Diagnostics Quarterly Data
	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12
COGS-to-Revenue	Get a 7-Day Free Trial															0.59	0.63	0.68	0.52	0.54

Hemagen Diagnostics COGS-to-Revenue Calculation

Hemagen Diagnostics's COGS to Revenue for the fiscal year that ended in Sep. 2012 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2.429	/	4.042
	=	0.60

Hemagen Diagnostics's COGS to Revenue for the quarter that ended in Sep. 2012 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.474	/	0.876
	=	0.54

Hemagen Diagnostics (OTCPK:HMGN) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Hemagen Diagnostics's Gross Margin % for the three months ended in Sep. 2012 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.474 / 0.876
	=	45.89 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Hemagen Diagnostics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

9033 Red Branch Road, Columbia, MD, USA, 21045

Website

http://www.hemagen.com

Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.

Executives

Howard F Curd

director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines